Our data have revealed dissociation between increased blood IFN-α2a levels and enhanced type I IFN–associated transcriptional scores in whole blood and low IFNA2 transcriptional levels in whole blood from patients with COVID-19. This evidence concerns the gene IGKV2D-29 and COVID-19.